# Novel Markers of Disease Progression in Interstitial Lung Disease

> **NCT05760508** · — · UNKNOWN · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 120 (actual)

## Conditions studied

- Interstitial Lung Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05760508
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-23
- **Primary completion:** 2022-03-30
- **Final completion:** 2024-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05760508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05760508, "Novel Markers of Disease Progression in Interstitial Lung Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05760508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*